This US-based investigation surveyed racial and ethnic disparities in the use of statins and aspirin among 3005 older community-dwelling adults (aged 57–85 years) at low (n=812), moderate (n=977), and high risk (n=1066) for cardiovascular disease (CVD) between June 2005 and March 2006. The paper reports the highest rates of use among respondents at high cardiovascular risk. Racial differences were highest among respondents at high risk, with Blacks less likely than Whites to use statins (38% vs 50%) and aspirin (29% vs 44%). Racial/ethnic disparities persisted after controlling for confounding factors.